Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers-Reference-Cited by-同舟云学术

Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers

Published:2017 Issue:5 Volume:8 Page:3427-3433
ISSN:2041-6520
Container-title:Chemical Science
language:en
Short-container-title:Chem. Sci.

Author:

Renoux Brigitte¹²³⁴⁵,Raes Florian⁶³⁷⁸,Legigan Thibaut¹²³⁴⁵,Péraudeau Elodie²³⁵⁸⁹,Eddhif Balkis¹²³⁵⁸,Poinot Pauline¹²³⁵⁸,Tranoy-Opalinski Isabelle¹²³⁴⁵,Alsarraf Jérôme¹²³⁴⁵,Koniev Oleksandr¹⁰¹¹⁸,Kolodych Sergii¹⁰¹¹⁸,Lerondel Stéphanie⁶³⁷⁸,Le Pape Alain⁶³⁷⁸,Clarhaut Jonathan¹²³⁴⁵,Papot Sébastien¹²³⁴⁵^ORCID

Affiliation:

1. Institut de Chimie des Milieux et des Matériaux de Poitiers (IC2MP)

2. Université de Poitiers

3. CNRS

4. Groupe “Systèmes Moléculaires Programmés”

5. F-86073 Poitiers

6. UPS no. 44 PHENOMIN TAAM-CIPA

7. F-45071 Orléans

8. France

9. CHU de Poitiers

10. Syndivia SAS

11. 67400 Illkirch

Abstract

A drug delivery system targeting the tumour microenvironment produces outstanding therapeutic efficacy on triple-negative mammary and pancreatic models.

Funder

Agence Nationale de la Recherche

Centre National de la Recherche Scientifique

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2017/SC/C7SC00472A

Reference36 articles.

1. Antibody-Drug Conjugates: An Emerging Concept in Cancer Therapy

2. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance